Country: Израел
Језик: Енглески
Извор: Ministry of Health
EXEMESTANE
VITAMED PHARMACEUTICAL INDUSTRIES LTD
L02BG06
FILM COATED TABLETS
EXEMESTANE 25 MG
PER OS
Required
GENEPHARM S.A., GREECE
EXEMESTANE
Exemasin-VIT is indicated for the treatment of advanced breast cancer (ABC) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone.Exemasin-VIT is also indicated for the treatment of postmenopausal women with ABC whose disease has progressed following multiple hormonal therapies. Exemasin-VIT is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.
2021-06-30
Patient leaflet in accordance with the Pharmacists' Regulations (Preparations) - 1986 This medicine can be sold with a physician's prescription only Exemasin-Vit, 25 mg, Coated tablets The active ingredient and its quantity: Each coated tablet contains: exemestane 25 mg. Inactive ingredients and allergens in the medicine- see section 6 "Additional information" and in section 2 "Important information about some of the ingredients of this medicine". Read the entire leaflet carefully before using this medicine. This leaflet contains concise information about this medicine. If you have any further questions, refer to the doctor or pharmacist. This medicine has been prescribed to treat your illness. Do not pass it on to others. It may harm them, even if it seems to you that their illness is similar to yours. This medicine is not intended for children. 1. What is the medicine intended for? Exemasin-Vit is used to treat hormone dependent early breast cancer in postmenopausal women, after they have completed 2-3 years of treatment with the medicine tamoxifen. Additionally, Exemasin-Vit is used for the treatment of hormone dependent advanced breast cancer in women in postmenopausal status (natural or induced), whose disease has progressed following a single hormonal (anti-estrogen) therapy or several hormonal therapies. Therapeutic group: Steroidal inhibitors of the enzyme aromatase, anti-neoplastic (anti- cancer) agents. Exemasin-Vit belongs to a group of medicines known as aromatase inhibitors; aromatase is an enzyme required for the production of the female sex hormones - estrogens, especially in postmenopausal women. Reduction in estrogen levels in the body is a way of treating hormone dependent breast cancer. 2. Before using this medicine Do not use this medicine if you: • Are or have previously been hypersensitive (allergic) to the active ingredient (exemestane) or to any of the other ingredients this medicine contains (see section 6 "Additional information"). • Are pregnant, likely to be pregnant or breastfeedi Прочитајте комплетан документ